Effect of genotypic differences in CYP2C19 status on the cure rates for gastroesophageal reflux disease by lansoplazole

被引：0
|
作者：
Furuta, T [1 ]
Shirai, N [1 ]
Xiao, P [1 ]
Kajimura, M [1 ]
Hanai, H [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2203
引用
收藏
页码：A432 / A432
页数：1
相关论文
共 50 条
  • [21] CYP2C19 GENOTYPE VARIABILITY IN PATIENTS WITH REFRACTORY GASTROESOPHAGEAL REFLUX AFTER PERORAL ENDOSCOPIC MYOTOMY (POEM)
    Perbtani, Yaseen B.
    Westerveld, Donevan R.
    Yang, Dennis
    Draganov, Peter V.
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB205 - AB206
  • [22] Phenotypic-genotypic analysis of CYP2C19 in a Chinese population
    Feng, Huang
    fu, liangqing
    Wu, DeZheng
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 233 - 233
  • [23] Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19:: Evidence from clinical and pharmacokinetic data
    Schwab, M
    Klotz, U
    Hofmann, U
    Schaeffeler, E
    Leodolter, A
    Malfertheiner, P
    Treiber, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) : 627 - 634
  • [24] INDIVIDUAL DIFFERENCES OF CYP2C19 mRNA EXPRESSION AND CYP2C19 GENETIC POLYMORPHISM IN THE SMALL INTESTINE OF JAPANESE
    Hayashi, Mikihilo
    Kinoshita, Yoichi
    Takenoshita, Sachiko
    Kurnai, Toshio
    Matsumoto, Naoki
    Kobayashi, Shinichi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1106 - 1106
  • [25] CYP2C19 STATUS AND OUTCOMES IN THE EUCLID TRIAL
    Patel, Manesh R.
    Heizer, Gretchen
    Mahaffey, Kenneth
    Fowkes, F. Gerry
    Berger, Jeffrey
    Baumgartner, Iris
    Rockhold, Frank
    Held, Peter
    Katona, Brian
    Norgren, Lars
    Jones, William
    Blomster, Juuso
    Hiatt, William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 2087 - 2087
  • [26] Effect of clarithromycin on the metabolism of omeprazole in relation to genetic differences in CYP2C19
    Furuta, T
    Ohashi, K
    Kobayashi, K
    Iida, I
    Yoshida, H
    Takashima, M
    Kosuge, K
    Shirai, N
    Hanai, H
    Chiba, K
    Ishizaki, T
    Kaneko, E
    GASTROENTEROLOGY, 1999, 116 (04) : A1214 - A1214
  • [27] CYP2C19 genotype status and effect of omeprazole on intragastric pH.
    Furuta, T
    Ohashi, K
    Takashima, M
    Hanai, H
    Kubota, T
    Ishizaki, T
    Kaneko, E
    GASTROENTEROLOGY, 1998, 114 (04) : A127 - A127
  • [28] Cytochrome P4502C19 (CYP2C19) genotype status is not associated with cure rates of dual therapy with rabeprazole and amoxicillin for Helicobacter pylori.
    Uchihara, M
    Izumi, N
    Noguchi, O
    Asahina, Y
    Kanazawa, N
    Itakura, J
    Sakurai, K
    Tsuchiya, K
    Miyake, S
    Sakai, T
    GASTROENTEROLOGY, 2001, 120 (05) : A587 - A587
  • [29] Association Between CYP2C19*17 Alleles and pH Probe Testing Outcomes in Children With Symptomatic Gastroesophageal Reflux
    Franciosi, James P.
    Mougey, Edward B.
    Williams, Andre
    Gomez-Suarez, Roberto A.
    Thomas, Cameron
    Creech, Christa L.
    George, Katherine
    Corao, Diana
    Lima, John J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (01): : 89 - 96
  • [30] Evaluation of cyp2c19 genetic polymorphism on the accuracy of proton-pump inhibitor (PPI) test in the diagnosis of gastroesophageal reflux disease (GERD)
    Lin, Jaw-Town
    Lee, Yi-Chia
    Wang, Hsiu-Po
    Chiu, Han-Mo
    Huang, Shih-Pei
    Wit, Ming-Shiang
    GASTROENTEROLOGY, 2006, 130 (04) : A164 - A164
12345